Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 25 May 2007. doi:10.1136/jmg.2007.050328
Journal of Medical Genetics 2007;44:609-614
Copyright © 2007 by the BMJ Publishing Group Ltd.

ORIGINAL ARTICLE

Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2A

M Fanin, L Nardetto, A C Nascimbeni, E Tasca, M Spinazzi, R Padoan, C Angelini

Neuromuscular Centre, Department of Neurosciences, University of Padova, and Venetian Institute of Molecular Medicine, Padova, Italy

Correspondence to:
Dr. M Fanin
Venetian Institute of Molecular Medicine, via G. Orus 2, 35129 Padova, Italy; marina.fanin{at}unipd.it

Background: Limb girdle muscular dystrophy type 2A (LGMD2A) is characterised by wide variability in clinical features and rate of progression. Patients with two null mutations usually have a rapid course, but in the remaining cases (two missense mutations or compound heterozygote mutations) prognosis is uncertain.

Methods: We conducted what is to our knowledge the first systematic histopathological, biochemical and molecular investigation of 24 LGMD2A patients, subdivided according to rapid or slow disease progression, to determine if some parameters could correlate with disease progression.

Results: We found that muscle histopathology score and the extent of regenerating and degenerating fibres could be correlated with the rate of disease course when the biochemical and molecular data do not offer sufficient information. Comparison of clinical and muscle histopathological data between LGMD2A and four other types of LGMD (LGMD2B–E) also gave another important and novel result. We found that LGMD2A has significantly lower levels of dystrophic features (ie degenerating and regenerating fibres) and higher levels of chronic changes (ie lobulated fibres) compared with other LGMDs, particularly LGMD2B. These results might explain the observation that atrophic muscle involvement seems to be a clinical feature peculiar to LGMD2A patients.

Conclusions: Distinguishing patterns of muscle histopathological changes in LGMD2A might reflect the effects of a disease-specific pathogenetic mechanism and provide clues complementary to genetic data.

Abbreviations: LGMD, limb girdle muscular dystrophy

Keywords: limb girdle muscular dystrophy; LGMD2A; prognosis; calpain-3; regeneration


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Walker, M. P., Rajendra, T.K., Saieva, L., Fuentes, J. L., Pellizzoni, L., Matera, A. G. (2008). SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain. Hum Mol Genet 17: 3399-3410 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Genetics jobs

Genetics jobs